Project cooperationUpdated on 19 March 2026
Translational IVD diagnostics from nutritional immunity and metal-ion economy
Groupleader at Institute of Microbiology AS CR
Prague 4, Czech Republic
About
Our group offers translational expertise for next-generation, patient-centred infection diagnostics and IVD development. We work at the interface of nutritional immunity and host–pathogen metal-ion economy, developing non-invasive biomarker panels that combine host-response proteins, elemental signatures, and microbial siderophore/metallophore readouts. We contribute assay concept generation, biomarker selection, analytical workflows based on LC-MS, ICP-MS, and immunoassays, as well as clinically relevant sample strategies for bacterial, fungal, and polymicrobial infections. We are particularly interested in projects aiming to convert novel biomarkers into robust diagnostic solutions supported by evidence on analytical performance, clinical relevance, and regulatory readiness.
Topic
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Type
- Partner seeks Consortium/Coordinator
Attached files
Organisation
Similar opportunities
Project cooperation
CircRNA Biomarkers for Post-Infection Neurological Conditions
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
Lalit Kaurani
Group Leader at Institute of Physiology of the Czech Academy of Sciences
Prague, Czech Republic
Project cooperation
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Silvia Angeletti
Full Professor Clinical Pathology and Head of Laboratory Unit at Fondazione Policlinico Universitario Campus Bio-Medico
Rome, Italy
Project cooperation
Integrated Omics–Driven Diagnostic Innovation Laboratory
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Vel Murugan
Professor at AZ Board of Regents on behalf of Arizona State University
Tempe, United States